144 related articles for article (PubMed ID: 11778258)
1. [Detection and significance of interleukin-8,6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease].
Wang S; Xu F; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug; 23(8):465-7. PubMed ID: 11778258
[TBL] [Abstract][Full Text] [Related]
2. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
3. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
5. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
Hacievliyagil SS; Mutlu LC; Temel İ
Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
[TBL] [Abstract][Full Text] [Related]
6. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
7. [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease].
Wang Z; Yao WZ; Xia GG; Sun DJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):410-3. PubMed ID: 19031798
[TBL] [Abstract][Full Text] [Related]
8. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
9. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease].
Zhang Y; Yang SR; Cheng DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):287-90. PubMed ID: 17441351
[TBL] [Abstract][Full Text] [Related]
10. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
11. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
[TBL] [Abstract][Full Text] [Related]
12. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
13. Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness.
Betz R; Kohlhäufl M; Kassner G; Müllinger B; Maier K; Brand P; Weber N; Häussinger K; Heyder J; Frankenberger M
Lung; 2001; 179(2):119-33. PubMed ID: 11733854
[TBL] [Abstract][Full Text] [Related]
14. [Tumor necrosis factor in sputa of patients with bronchial asthma on exacerbation].
Taki F; Kondoh Y; Matsumoto K; Takagi K; Satake T; Taniguchi H; Matsuzaki M
Arerugi; 1991 Jun; 40(6):643-6. PubMed ID: 1892447
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients.
Salva PS; Doyle NA; Graham L; Eigen H; Doerschuk CM
Pediatr Pulmonol; 1996 Jan; 21(1):11-9. PubMed ID: 8776260
[TBL] [Abstract][Full Text] [Related]
18. [The levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma].
Shen F; Zhao MW; He B; Wang YZ; Yao WZ
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):888-90. PubMed ID: 15730730
[TBL] [Abstract][Full Text] [Related]
19. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
Yang YM; Sun TY; Liu XM
Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
[TBL] [Abstract][Full Text] [Related]
20. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]